Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 78

1.

Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.

Saung WT, Narasimhan S, Lohoff FW.

Hum Psychopharmacol. 2014 Apr 10. doi: 10.1002/hup.2404. [Epub ahead of print]

PMID:
24723432
[PubMed - as supplied by publisher]
2.

Identification of CHRNA5 rare variants in African-American heavy smokers.

Doyle GA, Chou AD, Saung WT, Lai AT, Lohoff FW, Berrettini WH.

Psychiatr Genet. 2014 Mar 27. [Epub ahead of print]

PMID:
24682045
[PubMed - as supplied by publisher]
3.

The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O'brien CP, Oslin DW, Lohoff FW, Berrettini WH.

Ann Hum Genet. 2014 Jan;78(1):33-9. doi: 10.1111/ahg.12046. Epub 2013 Nov 25.

PMID:
24359476
[PubMed - in process]
4.

Individual differences in the morphometry and activation of time perception networks are influenced by dopamine genotype.

Wiener M, Lee YS, Lohoff FW, Coslett HB.

Neuroimage. 2014 Apr 1;89:10-22. doi: 10.1016/j.neuroimage.2013.11.019. Epub 2013 Nov 19.

PMID:
24269802
[PubMed - in process]
5.

Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.

Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Pharmacogenomics J. 2013 Oct 15. doi: 10.1038/tpj.2013.30. [Epub ahead of print]

PMID:
24126707
[PubMed - as supplied by publisher]
6.

Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR.

Rickels K, Etemad B, Rynn MA, Lohoff FW, Mandos LA, Gallop R.

Psychother Psychosom. 2013;82(6):363-71. doi: 10.1159/000351410. Epub 2013 Sep 20.

PMID:
24061331
[PubMed - in process]
7.

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.

Zai CC, Tiwari AK, Mazzoco M, de Luca V, Müller DJ, Shaikh SA, Lohoff FW, Freeman N, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL.

J Psychiatr Res. 2013 Nov;47(11):1760-5. doi: 10.1016/j.jpsychires.2013.07.025. Epub 2013 Sep 6.

PMID:
24018103
[PubMed - in process]
8.

Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.

Cooper AJ, Narasimhan S, Rickels K, Lohoff FW.

Psychiatry Res. 2013 Dec 30;210(3):1299-300. doi: 10.1016/j.psychres.2013.07.038. Epub 2013 Aug 22.

PMID:
23972788
[PubMed - in process]
9.

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.

Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, Andreassen OA, Anjorin A, Anney R, Anttila V, Arking DE, Asherson P, Azevedo MH, Backlund L, Badner JA, Bailey AJ, Banaschewski T, Barchas JD, Barnes MR, Barrett TB, Bass N, Battaglia A, Bauer M, Bayés M, Bellivier F, Bergen SE, Berrettini W, Betancur C, Bettecken T, Biederman J, Binder EB, Black DW, Blackwood DH, Bloss CS, Boehnke M, Boomsma DI, Breen G, Breuer R, Bruggeman R, Cormican P, Buccola NG, Buitelaar JK, Bunney WE, Buxbaum JD, Byerley WF, Byrne EM, Caesar S, Cahn W, Cantor RM, Casas M, Chakravarti A, Chambert K, Choudhury K, Cichon S, Cloninger CR, Collier DA, Cook EH, Coon H, Cormand B, Corvin A, Coryell WH, Craig DW, Craig IW, Crosbie J, Cuccaro ML, Curtis D, Czamara D, Datta S, Dawson G, Day R, De Geus EJ, Degenhardt F, Djurovic S, Donohoe GJ, Doyle AE, Duan J, Dudbridge F, Duketis E, Ebstein RP, Edenberg HJ, Elia J, Ennis S, Etain B, Fanous A, Farmer AE, Ferrier IN, Flickinger M, Fombonne E, Foroud T, Frank J, Franke B, Fraser C, Freedman R, Freimer NB, Freitag CM, Friedl M, Frisén L, Gallagher L, Gejman PV, Georgieva L, Gershon ES, Geschwind DH, Giegling I, Gill M, Gordon SD, Gordon-Smith K, Green EK, Greenwood TA, Grice DE, Gross M, Grozeva D, Guan W, Gurling H, De Haan L, Haines JL, Hakonarson H, Hallmayer J, Hamilton SP, Hamshere ML, Hansen TF, Hartmann AM, Hautzinger M, Heath AC, Henders AK, Herms S, Hickie IB, Hipolito M, Hoefels S, Holmans PA, Holsboer F, Hoogendijk WJ, Hottenga JJ, Hultman CM, Hus V, Ingason A, Ising M, Jamain S, Jones EG, Jones I, Jones L, Tzeng JY, Kähler AK, Kahn RS, Kandaswamy R, Keller MC, Kennedy JL, Kenny E, Kent L, Kim Y, Kirov GK, Klauck SM, Klei L, Knowles JA, Kohli MA, Koller DL, Konte B, Korszun A, Krabbendam L, Krasucki R, Kuntsi J, Kwan P, Landén M, Långström N, Lathrop M, Lawrence J, Lawson WB, Leboyer M, Ledbetter DH, Lee PH, Lencz T, Lesch KP, Levinson DF, Lewis CM, Li J, Lichtenstein P, Lieberman JA, Lin DY, Linszen DH, Liu C, Lohoff FW, Loo SK, Lord C, Lowe JK, Lucae S, MacIntyre DJ, Madden PA, Maestrini E, Magnusson PK, Mahon PB, Maier W, Malhotra AK, Mane SM, Martin CL, Martin NG, Mattheisen M, Matthews K, Mattingsdal M, McCarroll SA, McGhee KA, McGough JJ, McGrath PJ, McGuffin P, McInnis MG, McIntosh A, McKinney R, McLean AW, McMahon FJ, McMahon WM, McQuillin A, Medeiros H, Medland SE, Meier S, Melle I, Meng F, Meyer J, Middeldorp CM, Middleton L, Milanova V, Miranda A, Monaco AP, Montgomery GW, Moran JL, Moreno-De-Luca D, Morken G, Morris DW, Morrow EM, Moskvina V, Muglia P, Mühleisen TW, Muir WJ, Müller-Myhsok B, Murtha M, Myers RM, Myin-Germeys I, Neale MC, Nelson SF, Nievergelt CM, Nikolov I, Nimgaonkar V, Nolen WA, Nöthen MM, Nurnberger JI, Nwulia EA, Nyholt DR, O'Dushlaine C, Oades RD, Olincy A, Oliveira G, Olsen L, Ophoff RA, Osby U, Owen MJ, Palotie A, Parr JR, Paterson AD, Pato CN, Pato MT, Penninx BW, Pergadia ML, Pericak-Vance MA, Pickard BS, Pimm J, Piven J, Posthuma D, Potash JB, Poustka F, Propping P, Puri V, Quested DJ, Quinn EM, Ramos-Quiroga JA, Rasmussen HB, Raychaudhuri S, Rehnström K, Reif A, Ribasés M, Rice JP, Rietschel M, Roeder K, Roeyers H, Rossin L, Rothenberger A, Rouleau G, Ruderfer D, Rujescu D, Sanders AR, Sanders SJ, Santangelo SL, Sergeant JA, Schachar R, Schalling M, Schatzberg AF, Scheftner WA, Schellenberg GD, Scherer SW, Schork NJ, Schulze TG, Schumacher J, Schwarz M, Scolnick E, Scott LJ, Shi J, Shilling PD, Shyn SI, Silverman JM, Slager SL, Smalley SL, Smit JH, Smith EN, Sonuga-Barke EJ, St Clair D, State M, Steffens M, Steinhausen HC, Strauss JS, Strohmaier J, Stroup TS, Sutcliffe JS, Szatmari P, Szelinger S, Thirumalai S, Thompson RC, Todorov AA, Tozzi F, Treutlein J, Uhr M, van den Oord EJ, Van Grootheest G, Van Os J, Vicente AM, Vieland VJ, Vincent JB, Visscher PM, Walsh CA, Wassink TH, Watson SJ, Weissman MM, Werge T, Wienker TF, Wijsman EM, Willemsen G, Williams N, Willsey AJ, Witt SH, Xu W, Young AH, Yu TW, Zammit S, Zandi PP, Zhang P, Zitman FG, Zöllner S; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC), Devlin B, Kelsoe JR, Sklar P, Daly MJ, O'Donovan MC, Craddock N, Sullivan PF, Smoller JW, Kendler KS, Wray NR.

Nat Genet. 2013 Sep;45(9):984-94. doi: 10.1038/ng.2711. Epub 2013 Aug 11.

PMID:
23933821
[PubMed - indexed for MEDLINE]
10.

Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.

Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Anil Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.

Mol Psychiatry. 2014 Apr;19(4):403-5. doi: 10.1038/mp.2013.74. Epub 2013 Jun 11. No abstract available.

PMID:
23752246
[PubMed - in process]
11.

Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.

Cooper AJ, Rickels K, Lohoff FW.

Hum Psychopharmacol. 2013 May;28(3):258-62. doi: 10.1002/hup.2317. Epub 2013 May 8.

PMID:
23658070
[PubMed - indexed for MEDLINE]
12.

An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ, Ling W, Hillhouse MP, Bruce RD, Woody G, Berrettini WH.

Neuropsychopharmacology. 2013 Sep;38(10):2003-10. doi: 10.1038/npp.2013.99. Epub 2013 Apr 23. Erratum in: Neuropsychopharmacology. 2014 Mar;39(4):1039.

PMID:
23612435
[PubMed - indexed for MEDLINE]
13.

Case-control association study of WLS variants in opioid and cocaine addicted populations.

Crist RC, Ambrose-Lanci LM, Zeng A, Yuan C, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Ferraro TN, Doyle GA, Lohoff FW, Berrettini WH.

Psychiatry Res. 2013 Jun 30;208(1):62-6. doi: 10.1016/j.psychres.2013.03.011. Epub 2013 Apr 5.

PMID:
23566366
[PubMed - indexed for MEDLINE]
14.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH.

Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20.

PMID:
23454283
[PubMed - indexed for MEDLINE]
15.

COMT and ANKK1-Taq-Ia genetic polymorphisms influence visual working memory.

Berryhill ME, Wiener M, Stephens JA, Lohoff FW, Coslett HB.

PLoS One. 2013;8(1):e55862. doi: 10.1371/journal.pone.0055862. Epub 2013 Jan 31.

PMID:
23383291
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing.

Lohoff FW, Hodge R, Narasimhan S, Nall A, Ferraro TN, Mickey BJ, Heitzeg MM, Langenecker SA, Zubieta JK, Bogdan R, Nikolova YS, Drabant E, Hariri AR, Bevilacqua L, Goldman D, Doyle GA.

Mol Psychiatry. 2014 Jan;19(1):129-39. doi: 10.1038/mp.2012.193. Epub 2013 Jan 22.

PMID:
23337945
[PubMed - in process]
17.

VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Multani PK, Hodge R, Estévez MA, Abel T, Kung H, Alter M, Brookshire B, Lucki I, Nall AH, Talbot K, Doyle GA, Lohoff FW.

Neuroscience. 2012 Nov 29;232C:32-44. doi: 10.1016/j.neuroscience.2012.11.023. [Epub ahead of print]

PMID:
23201251
[PubMed - as supplied by publisher]
18.

Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene.

Wetherill RR, Jagannathan K, Lohoff FW, Ehrman R, O'Brien CP, Childress AR, Franklin TR.

Addict Biol. 2014 Mar;19(2):294-304. doi: 10.1111/j.1369-1600.2012.00507.x. Epub 2012 Oct 12.

PMID:
23061530
[PubMed - in process]
19.

Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans.

Multani PK, Clarke TK, Narasimhan S, Ambrose-Lanci L, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Berrettini WH, Lohoff FW.

Neurosci Lett. 2012 Nov 30;531(1):46-51. doi: 10.1016/j.neulet.2012.09.014. Epub 2012 Sep 20.

PMID:
22999924
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Evidence for the use of vilazodone in the treatment of major depressive disorder.

Reinhold JA, Mandos LA, Lohoff FW, Rickels K.

Expert Opin Pharmacother. 2012 Oct;13(15):2215-24. doi: 10.1517/14656566.2012.721776. Epub 2012 Sep 13. Review.

PMID:
22970859
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk